25 May 2013
Keywords: rotarix, provides, broad, protection, eu, trial, new
Article | 03 December 2007
New data from a large-scale European trial of GlaxoSmithKline's oral
rotavirus vaccine Rotarix suggest that the agent prevents infection by
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 December 2007
24 May 2013
© 2013 thepharmaletter.com